UBS Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82M | Buy |
4,735,311
+1,463,117
| +45% | +$25.3M | 0.01% | 900 |
|
|
2025
Q1 | $71.6M | Buy |
3,272,194
+685,455
| +26% | +$15M | 0.01% | 928 |
|
|
2024
Q4 | $82.5M | Buy |
2,586,739
+2,272,055
| +722% | +$72.5M | 0.02% | 803 |
|
|
2024
Q3 | $9.08M | Buy |
314,684
+42,287
| +16% | +$1.22M | ﹤0.01% | 1755 |
|
|
2024
Q2 | $10.4M | Buy |
272,397
+161,105
| +145% | +$6.18M | ﹤0.01% | 1586 |
|
|
2024
Q1 | $6.54M | Buy |
111,292
+16,258
| +17% | +$956K | ﹤0.01% | 1946 |
|
|
2023
Q4 | $5.69M | Buy |
95,034
+91,168
| +2,358% | +$5.46M | ﹤0.01% | 1909 |
|
|
2023
Q3 | $147K | Sell |
3,866
-92,589
| -96% | -$3.52M | ﹤0.01% | 4479 |
|
|
2023
Q2 | $8.79M | Sell |
96,455
-7,909
| -8% | -$721K | ﹤0.01% | 1495 |
|
|
2023
Q1 | $6.88M | Sell |
104,364
-27,533
| -21% | -$1.82M | ﹤0.01% | 1617 |
|
|
2022
Q4 | $6.82M | Buy |
131,897
+117,258
| +801% | +$6.06M | ﹤0.01% | 1603 |
|
|
2022
Q3 | $1M | Sell |
14,639
-57,484
| -80% | -$3.93M | ﹤0.01% | 2850 |
|
|
2022
Q2 | $3.26M | Sell |
72,123
-42,526
| -37% | -$1.92M | ﹤0.01% | 2058 |
|
|
2022
Q1 | $5.83M | Buy |
114,649
+5,262
| +5% | +$267K | ﹤0.01% | 1812 |
|
|
2021
Q4 | $5.17M | Sell |
109,387
-87,495
| -44% | -$4.14M | ﹤0.01% | 2056 |
|
|
2021
Q3 | $6.49M | Buy |
196,882
+140,763
| +251% | +$4.64M | ﹤0.01% | 1787 |
|
|
2021
Q2 | $3.55M | Buy |
56,119
+44,425
| +380% | +$2.81M | ﹤0.01% | 2290 |
|
|
2021
Q1 | $502K | Buy |
11,694
+10,663
| +1,034% | +$458K | ﹤0.01% | 3923 |
|
|
2020
Q4 | $59K | Buy |
1,031
+738
| +252% | +$42.2K | ﹤0.01% | 5042 |
|
|
2020
Q3 | $9K | Sell |
293
-2,527
| -90% | -$77.6K | ﹤0.01% | 6034 |
|
|
2020
Q2 | $92K | Sell |
2,820
-10,118
| -78% | -$330K | ﹤0.01% | 4542 |
|
|
2020
Q1 | $347K | Sell |
12,938
-5,933
| -31% | -$159K | ﹤0.01% | 3503 |
|
|
2019
Q4 | $578K | Sell |
18,871
-11,981
| -39% | -$367K | ﹤0.01% | 3781 |
|
|
2019
Q3 | $743K | Sell |
30,852
-15,674
| -34% | -$377K | ﹤0.01% | 3424 |
|
|
2019
Q2 | $1.18M | Buy |
46,526
+37,175
| +398% | +$942K | ﹤0.01% | 2928 |
|
|
2019
Q1 | $182K | Sell |
9,351
-54,828
| -85% | -$1.07M | ﹤0.01% | 3898 |
|
|
2018
Q4 | $847K | Buy |
64,179
+38,146
| +147% | +$503K | ﹤0.01% | 3115 |
|
|
2018
Q3 | $463K | Buy |
26,033
+19,544
| +301% | +$348K | ﹤0.01% | 3695 |
|
|
2018
Q2 | $143K | Buy |
6,489
+1,298
| +25% | +$28.6K | ﹤0.01% | 4322 |
|
|
2018
Q1 | $115K | Buy |
5,191
+1,288
| +33% | +$28.5K | ﹤0.01% | 4312 |
|
|
2017
Q4 | $85K | Buy |
+3,903
| New | +$85K | ﹤0.01% | 4534 |
|